PMD-200™ and the NOL® index are commercially available in Australia!

1 Oct 2018 News and Events

We are happy to share with you the Medasense received approval to market the PMD-200™ system in Australia.

The PMD-200™ and its NOL® index are currently commercially available in Europe, Canada, Australia and Israel.

Please note that it is not commercially available yet in the U.S.A.



* Image Designed by Ibrandify